ArticleMolecular cancer therapeutics2020

A Genome-scale CRISPR Screen Identifies the ERBB and mTOR Signaling Networks as Key Determinants of Response to PI3K Inhibition in Pancreatic Cancer.

Charlotte K Milton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.